3D printing of 5-drug polypill

Journal of Controlled Release

Volumn 217, Issue , 2015, Pages 352-

  Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; ETIRACETAM; EXCIPIENT; DRUG COMBINATION; TABLET;

CONTROLLED CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; PATIENT COMPLIANCE; PATIENT SAFETY; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEIZURE; TABLET; TABLET FORMULATION; TABLET MANUFACTURE; THREE DIMENSIONAL PRINTING; CHEMISTRY; DRUG COMBINATION; PHARMACOKINETICS;

DRUG COMBINATIONS; HUMANS; PRECISION MEDICINE; PRINTING, THREE-DIMENSIONAL; TABLETS;

EID: 84944737782     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.10.014     Document Type: Editorial

References (2)

1. S.A. Khaled, J.C. Burley, M.R. Alexander, J. Yang, and C.J. Roberts 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles J. Control. Release 217 2015 308 314
2. https://www.aprecia.com/pdf/2015-08-03-Spritam-FDA-Approval-Press-Release.pdf